BACKGROUND: There are limited and conflicting data on clinical outcomes of community-acquired pneumonia (CAP) among HIV-infected patients. METHODS: Secondary analyses of clinical outcomes of CAP were performed for 118 patients with HIV infection and 2790 patients without HIV infection enrolled in the Community-Acquired Pneumonia Organization (CAPO) international study. After adjustment for significant confounders, the effect of HIV infection on length of stay (LOS) and time to clinical stability (TCS) were examined by survival analyses and overall mortality and CAP-related mortality by logistic regression methods. RESULTS: After adjusting for significant confounders, hospitalized HIV-infected patients with CAP did not have longer times to reach clinical stability (HR 1.126; 95% CI 0.917-1.391; p=0.251) or longer stays in the hospital (HR 1.191, 95% CI 0.979-1.449; p=0.080). In addition, HIV infection did not significantly influence overall mortality rates (OR 1.205, 95% CI 0.686-2.116; p=0.517) or CAP-related mortality rates (OR 1.338; 95% CI 0.623-3.725; p=0.355). CONCLUSION: The presence of HIV infection did not influence the clinical outcomes of CAP among patients assessed at CAPO centers. It is not intended that our results be extrapolated to populations receiving limited healthcare for advanced HIV disease, malnourishment and parasitic diseases. Copyright 2009 International Society for Infectious Diseases. All rights reserved.
BACKGROUND: There are limited and conflicting data on clinical outcomes of community-acquired pneumonia (CAP) among HIV-infectedpatients. METHODS: Secondary analyses of clinical outcomes of CAP were performed for 118 patients with HIV infection and 2790 patients without HIV infection enrolled in the Community-Acquired Pneumonia Organization (CAPO) international study. After adjustment for significant confounders, the effect of HIV infection on length of stay (LOS) and time to clinical stability (TCS) were examined by survival analyses and overall mortality and CAP-related mortality by logistic regression methods. RESULTS: After adjusting for significant confounders, hospitalized HIV-infectedpatients with CAP did not have longer times to reach clinical stability (HR 1.126; 95% CI 0.917-1.391; p=0.251) or longer stays in the hospital (HR 1.191, 95% CI 0.979-1.449; p=0.080). In addition, HIV infection did not significantly influence overall mortality rates (OR 1.205, 95% CI 0.686-2.116; p=0.517) or CAP-related mortality rates (OR 1.338; 95% CI 0.623-3.725; p=0.355). CONCLUSION: The presence of HIV infection did not influence the clinical outcomes of CAP among patients assessed at CAPO centers. It is not intended that our results be extrapolated to populations receiving limited healthcare for advanced HIV disease, malnourishment and parasitic diseases. Copyright 2009 International Society for Infectious Diseases. All rights reserved.
Authors: L A Barakat; M Juthani-Mehta; H Allore; M Trentalange; J Tate; D Rimland; M Pisani; K M Akgün; M B Goetz; A A Butt; M Rodriguez-Barradas; M Duggal; K Crothers; A C Justice; V J Quagliarello Journal: HIV Med Date: 2015-05-11 Impact factor: 3.180
Authors: Eric Walter Pefura Yone; Adamou Dodo Balkissou; André Pascal Kengne; Christopher Kuaban Journal: BMC Pulm Med Date: 2012-08-30 Impact factor: 3.317
Authors: Rulan Griesel; Annemie Stewart; Helen van der Plas; Welile Sikhondze; Marc Mendelson; Gary Maartens Journal: AIDS Res Ther Date: 2018-02-12 Impact factor: 2.250
Authors: Sebastien Kenmoe; Jean Joel Bigna; Abdou Fatawou Modiyingi; Marie S Ndangang; Paul Alain Ngoupo; Fredy Brice N Simo; Serges Tchatchouang; Elvis Temfack; Richard Njouom Journal: J Clin Virol Date: 2019-06-28 Impact factor: 3.168